Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Walldius

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Acta Radiologica (Stockholm, Sweden : 1987)|November 1, 1993
Reproducibility of quantitative arteriographic assessment of atherosclerosis in the femoral arteryL Bergstrand, U Erikson, I Holme, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 1, 1995
Lowering of HDL2b by probucol partly explains the failure of the drug to affect femoral atherosclerosis in subjects with hypercholesterolemia. A Probucol Quantitative Regression Swedish Trial (PQRST) ReportJ Johansson, A G Olsson, L Bergstrand, et al.
Atherosclerosis|September 6, 1996
The effect of probucol on low density lipoprotein oxidation and femoral atherosclerosisJ Regnström, G Walldius, S Nilsson, et al.
Acta Medica Scandinavica|January 1, 1988
Serum apolipoproteins, lipoproteins and fatty acids in relation to ischaemic heart disease in northern and southern European malesA G Olsson, L Holmquist, G Walldius, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|July 1, 1990
Arterial segmental vasoconstriction in hypercholesterolaemic patientsS Nilsson, I Berglund, A Christoffersson, et al.
The American Journal of Cardiology|February 25, 1993
The role of lipids and antioxidative factors for development of atherosclerosis. The Probucol Quantitative Regression Swedish Trial (PQRST)G Walldius, J Regnström, J Nilsson, et al.
The American Journal of Cardiology|November 1, 1994
The effect of probucol on femoral atherosclerosis: the Probucol Quantitative Regression Swedish Trial (PQRST)G Walldius, U Erikson, A G Olsson, et al.
The American Journal of Cardiology|July 25, 1988
Development of femoral atherosclerosis in hypercholesterolemic patients during treatment with cholestyramine and probucol/placebo: Probucol Quantitative Regression Swedish Trial (PQRST): a status reportG Walldius, L A Carlson, U Erikson, et al.
Statistics in Medicine|February 25, 2017
A latent class model for competing risksM Rowley, H Garmo, M Van Hemelrijck, et al.
International Journal of Cancer|January 12, 2018
Serum inflammatory markers in relation to prostate cancer severity and death in the Swedish AMORIS studyR Arthur, R Williams, H Garmo, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Acta Radiologica (Stockholm, Sweden : 1987)|November 1, 1993
Reproducibility of quantitative arteriographic assessment of atherosclerosis in the femoral arteryL Bergstrand, U Erikson, I Holme, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 1, 1995
Lowering of HDL2b by probucol partly explains the failure of the drug to affect femoral atherosclerosis in subjects with hypercholesterolemia. A Probucol Quantitative Regression Swedish Trial (PQRST) ReportJ Johansson, A G Olsson, L Bergstrand, et al.
Atherosclerosis|September 6, 1996
The effect of probucol on low density lipoprotein oxidation and femoral atherosclerosisJ Regnström, G Walldius, S Nilsson, et al.
Acta Medica Scandinavica|January 1, 1988
Serum apolipoproteins, lipoproteins and fatty acids in relation to ischaemic heart disease in northern and southern European malesA G Olsson, L Holmquist, G Walldius, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|July 1, 1990
Arterial segmental vasoconstriction in hypercholesterolaemic patientsS Nilsson, I Berglund, A Christoffersson, et al.
The American Journal of Cardiology|February 25, 1993
The role of lipids and antioxidative factors for development of atherosclerosis. The Probucol Quantitative Regression Swedish Trial (PQRST)G Walldius, J Regnström, J Nilsson, et al.
The American Journal of Cardiology|November 1, 1994
The effect of probucol on femoral atherosclerosis: the Probucol Quantitative Regression Swedish Trial (PQRST)G Walldius, U Erikson, A G Olsson, et al.
The American Journal of Cardiology|July 25, 1988
Development of femoral atherosclerosis in hypercholesterolemic patients during treatment with cholestyramine and probucol/placebo: Probucol Quantitative Regression Swedish Trial (PQRST): a status reportG Walldius, L A Carlson, U Erikson, et al.
Statistics in Medicine|February 25, 2017
A latent class model for competing risksM Rowley, H Garmo, M Van Hemelrijck, et al.
International Journal of Cancer|January 12, 2018
Serum inflammatory markers in relation to prostate cancer severity and death in the Swedish AMORIS studyR Arthur, R Williams, H Garmo, et al.
Pageof 9